Superworth

Large drugmakers with the fastest revenue growth

Revenue over the last twelve months against the twelve months before. As of .

Ranked
97
of 411 large drugmakers we cover
Median
+11.7%
Highest
+280.5%
CRMD
Range
−70.1% to +280.5%
median +11.7%
−55.3%+202.4%
#CompanyRevenue growthNet marginPrice to salesMarket cap
1CRMDCorMedix+280.5%40.5%0.9×$420.1M
2BBIOBridgeBio Pharma+202.4%−97.0%20.6×$14.7B
3BCYCBicycle Therapeutics+194.7%n/m3.0×$253.7M
4SNDXSyndax Pharmaceuticals+159.7%−87.5%4.6×$1.2B
5MDGLMadrigal Pharmaceuticals+149.0%−25.3%7.8×$10B
6AGIOAgios Pharmaceuticals+140.6%n/m18.2×$1.8B
7ASMBAssembly Biosciences+125.1%−0.1%5.3×$397.2M
8TNGXTango Therapeutics+121.5%n/m68.2×$3.7B
9ZVRAZevra Therapeutics+119.4%42.8%4.4×$599.8M
10ABCLAbCellera Biologics+101.3%n/m51.5×$3.4B
11URGNUroGen Pharma+100.3%−51.7%8.9×$1.7B
12PHATPhathom Pharmaceuticals+86.8%−30.2%1.7×$480.8M
13ARQTArcutis Biotherapeutics+76.1%6.1%8.5×$3.9B
14TGTXTG Therapeutics+76.1%55.2%11.5×$9.2B
15KNSAKiniksa Pharmaceuticals International+58.9%9.6%8.4×$7.1B
16AXSMAxsome Therapeutics+56.9%−24.7%9.2×$7.1B
17LGNDLigand Pharmaceuticals+54.9%67.9%21.1×$6.1B
18RYTMRhythm Pharmaceuticals+53.5%−85.6%26.8×$6.4B
19TVTXTravere Therapeutics+49.4%−7.4%7.9×$4.6B
20LLYEli Lilly and+45.5%31.9%15.6×$1.3T
21MIRMMirum Pharmaceuticals+44.0%n/m9.0×$5.6B
22XERSXeris Biopharma+36.3%−5.1%5.5×$1.9B
23PTGXProtagonist Therapeutics+34.8%29.4%32.0×$9B
24GOSSGossamer Bio+32.4%n/m1.1×$57.7M
25ANIPANI Pharmaceuticals+30.9%11.1%1.7×$1.6B
26MNKDMannkind+30.5%−11.1%3.0×$1.2B
27SUPNSupernus Pharmaceuticals+26.9%−5.1%2.4×$2.1B
28IRWDIronwood Pharmaceuticals+26.2%33.4%1.5×$571.7M
29GERNGeron+24.4%−33.1%2.9×$596.9M
30HRMYHarmony Biosciences+24.3%18.9%2.3×$2.2B
31AQSTAquestive Therapeutics+22.6%n/m8.7×$473.2M
32HROWHarrow+21.1%−13.5%3.8×$1.1B
33AUPHAurinia Pharmaceuticals+21.0%97.7%6.7×$2.2B
34DERMJourney Medical+20.9%−9.0%2.0×$135.2M
35INVAInnoviva+18.8%81.2%3.5×$1.5B
36RAREUltragenyx Pharmaceutical+17.4%−81.7%2.2×$1.6B
37PAHCPhibro Animal Health+17.1%6.6%1.0×$1.6B
38ARWRArrowhead Pharmaceuticals+16.8%−47.8%12.6×$8.4B
39ARDXArdelyx+16.8%−12.4%1.7×$755M
40INDVIndivior Pharmaceuticals+16.3%32.8%3.1×$4.3B
41CORTCorcept Therapeutics+16.0%6.6%10.5×$8.7B
42COLLCollegium Pharmaceutical+14.3%5.9%1.0×$770.9M
43EOLSEvolus+13.9%−10.8%1.5×$472.9M
44GYREGyre Therapeutics+13.5%−15.5%4.4×$527.4M
45JAZZJazz Pharmaceuticals+12.6%20.4%3.0×$13.9B
46CYRXCryoport+12.1%−20.1%4.4×$822M
47ELANElanco Animal Health+12.0%−4.0%2.4×$12B
48ACADAcadia Pharmaceuticals+11.8%33.4%3.1×$3.5B
49MGNXMacrogenics+11.7%−8.7%0.9×$148.4M
50BMRNBiomarin Pharmaceutical+11.2%2.1%3.3×$11.1B
51BHCBausch Health Companies+10.8%−7.6%0.3×$3B
52ALKSAlkermes plc.+10.8%4.0%4.5×$7.5B
53ABBVAbbVie+10.7%15.7%7.7×$511.6B
54AMRXAmneal Pharmaceuticals+9.3%5.0%2.1×$6.5B
55AMGNAmgen+9.1%23.0%6.6×$252.3B
56SDGRSchrodinger+8.9%−21.0%7.6×$2B
57VNDAVanda Pharmaceuticals+8.1%n/m1.0×$234.6M
58JNJJohnson & Johnson+7.8%n/m6.5×$650.2B
59AKBAAkebia Therapeutics+7.5%−13.5%0.9×$196.3M
60KPTIKaryopharm Therapeutics+6.8%n/m0.0×$2.5M
61NATRNatures Sunshine Products+6.8%3.7%0.4×$211.5M
62GILDGilead Sciences+6.5%−12.5%6.9×$212.5B
63ORGOOrganogenesis+6.5%−18.4%0.2×$97.2M
64PCRXPacira BioSciences+5.7%2.0%1.9×$1.5B
65ZLABZai Lab+5.1%−41.9%5.4×$2.4B
66MRKMerck+4.9%3.6%5.3×$359.5B
67BMYBristol-Myers Squibb+4.2%18.5%2.6×$128.7B
68SPRYARS Pharmaceuticals+4.1%n/m2.6×$303.3M
69RIGLRigel Pharmaceuticals+3.3%n/m3.4×$943.9M
70ADCTADC Therapeutics SA+3.0%n/m2.5×$196.6M
71AMPHAmphastar Pharmaceuticals+1.0%10.8%1.6×$1.1B
72HRTXHeron Therapeutics+1.0%−22.5%0.4×$56M
73ENTAEnanta Pharmaceuticals+0.7%−96.9%4.7×$303.8M
74BIIBBiogen+0.3%8.3%3.7×$37B
75PFEPfizer−0.2%6.8%2.8×$176B
76PBHPrestige Consumer Healthcare−1.4%15.6%2.1×$2.4B
77PBYIPuma Biotechnology−2.9%11.6%2.3×$525.5M
78OGNOrganon−3.2%3.5%0.6×$3.6B
79PRGOPERRIGO−4.2%−41.9%0.5×$2.2B
80MRVIMaravai Lifesciences−5.0%−37.1%8.9×$1.9B
81IONSIonis Pharmaceuticals−7.4%−64.7%7.8×$6.9B
82OCULOcular Therapeutix−8.1%n/m28.4×$1.5B
83OPKOpko Health−11.5%−12.4%2.2×$1.3B
84AYTUAytu Biopharma−13.3%−24.8%0.4×$21.1M
85ARVNArvinas−15.0%2.9%1.6×$491.7M
86AMRNAmarin Corp Plc−15.1%−14.6%1.4×$256.2M
87EBSEmergent BioSolutions−17.7%−23.0%0.4×$330.2M
88LFVNLifevantage−20.1%2.8%0.4×$73.5M
89SRPTSarepta Therapeutics−20.4%−6.9%1.0×$1.9B
90CYTKCytokinetics−21.1%n/m127×$8.6B
91RMTIRockwell Medical−21.1%−7.3%0.4×$27.9M
92LABStandard Biotools−23.6%n/m2.8×$239.4M
93NKTRNektar Therapeutics−27.2%n/m23.1×$1.3B
94XNCRXencor−28.6%n/m21.0×$2.2B
95PTCTPTC Therapeutics−35.1%−9.2%4.4×$5.1B
96RCUSArcus Biosciences−55.3%n/m19.4×$2.3B
97SIGASiga Technologies−70.1%−5.2%4.0×$212M

Not ranked: 108 with not a meaningful number, 61 with a quarter missing, 53 with under $50M of revenue, 15 with growth from a base too small to compare. 77 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

Revenue growth for other groups

Other rankings of large drugmakers

The group